Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: An epidemic of viral-induced carcinoma?-Reference-Cited by-同舟云学术

Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: An epidemic of viral-induced carcinoma?

Published:2009-07-15 Issue:2 Volume:125 Page:362-366
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Näsman Anders,Attner Per,Hammarstedt Lalle,Du Juan,Eriksson Mathilda,Giraud Geraldine,Ährlund-Richter Sofie,Marklund Linda,Romanitan Mircea,Lindquist David,Ramqvist Torbjörn,Lindholm Johan,Sparén Pär,Ye Weimin,Dahlstrand Hanna,Munck-Wikland Eva,Dalianis Tina

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference32 articles.

1. The incidence of tonsillar cancer in Sweden is increasing;Hammarstedt;Acta Otolaryngol,2007

2. Changing patterns of tonsillar squamous cell carcinoma in the United States;Frisch;Cancer Causes Control,2000

3. Trends in palatine tonsillar cancer incidence and mortality rates in the United States;Golas;Community Dent Oral Epidemiol,2007

4. HPV infections and tonsillar carcinoma;Syrjanen;J Clin Pathol,2004

5. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck;Mork;N Engl J Med,2001

Cited by 612 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TNM 8 staging system beyond p16: double HPV/p16 status is superior to p16 alone in predicting outcome in oropharyngeal squamous cell carcinoma;European Journal of Cancer;2024-09

2. Transoral Robotic Surgery and Human Papillomavirus Infection: Impact on Oropharyngeal Cancer Prognosis;Journal of Clinical Medicine;2024-07-30

3. Epidemiological trends and survival of oropharyngeal cancer in a high HPV‐prevalent area: A Danish population‐based study from 2000 to 2020;International Journal of Cancer;2024-07-17

4. PET-CT-guided, symptom-based, patient-initiated surveillance versus clinical follow-up in head neck cancer patients (PETNECK2): study protocol for a multicentre feasibility study and non-inferiority, randomised, phase III trial;BMC Cancer;2024-07-10

5. The results of immunotherapy in patients with recurrent and metastatic human papilloma virus positive head and neck squamous cell carcinoma;Head and Neck Tumors (HNT);2024-06-27